4-Octyl itaconate通过调节巨核细胞自和亡来改善免疫性血栓缺血症

Yuying Chang1, Yinglan Jin1, Xi Chen1

  • 1Department of Hematology, the 2nd Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.

PubMed
概括

4-Octyl itaconate (4-OI) 治疗改善了免疫性血小板缩 (ITP) 的小鼠的血小板计数,通过促进巨核细胞亡和调节自. 这表明4-OI是ITP的潜在治疗方法.